AIM: to accelerate innovation in drug development for children and adolescents with cancer

The ACCELERATE international platform provides a transparent forum to discuss and address, in a timely fashion, overarching issues in the development of innovative anticancer medicines for children and adolescents with cancer. The ultimate goal is improvement in outcomes for children and adolescents with cancer. Patients and parents organisations, academic paediatric oncologists and haematologists, researchers, representatives from biopharma companies, regulatory networks and health technology assessment authorities are all equal members of ACCELERATE.
In June 2018, the ACCELERATE platform was reorganised to strengthen international cooperation in order to improve global development of new paediatric oncology drugs.